110 results
8-K
EX-10.1
SYRE
Spyre Therapeutics Inc.
25 Apr 24
Unregistered Sales of Equity Securities
4:21pm
.
[Signature Page Follows]
Please sign to acknowledge agreement with the above terms and return to the undersigned.
Stockholder:
FAIRMOUNT HEALTHCARE FUND … II L.P.
By: Fairmount Healthcare Fund II GP LLC
By: /s/ Tomas Kiselak
Name: Tomas Kiselak
Title: Managing Member
Acknowledged and agreed to:
SPYRE
8-K
SYRE
Spyre Therapeutics Inc.
25 Apr 24
Unregistered Sales of Equity Securities
4:21pm
, 2024, by and between the Company and Fairmount Healthcare Fund II L.P.
Cover Page Interactive Data File (embedded within the Inline XBRL document
POS AM
zpfekkvd24
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
424B3
svml6bf0x bw4pr
18 Mar 24
Prospectus supplement
4:06pm
8-K
EX-10.1
wt4zl7g4u7rh4 6vnyt
18 Mar 24
Spyre Therapeutics Announces $180 Million Private Placement
8:31am
POS AM
jgzseaks4a45kr38z
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
POS AM
6vx9l vhub
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
424B3
fz3djmwm0ey 4v
6 Feb 24
Prospectus supplement
9:37pm
8-K
EX-10.1
xgl ez55z4t9b
5 Feb 24
Entry into a Material Definitive Agreement
7:36am